Please enable JavaScript.

Coggle requires JavaScript to display documents.

Male Hormonal drugs, Female Hormonal drugs - Coggle Diagram

- - - - Known hypersensitivity to the drug.
      - Males with carcinoma of the breast.
      - Males with known or suspected carcinoma of the prostate gland.
      - Patients with serious cardiac, hepatic or renal disease
      - Nodules upon digital rectal examination
    - - Pain and redness at the injection site may also occur.
      - Nausea
      - Vomiting
      - Increased/decreased sexual interest
      - Skin color changes
      - Oily skin, hair loss, and acne may occur.
      - Headache
    - - Store at 20° to 25°C
    - - Is for intramuscular use only.
      - Intramuscular injections should be given deep in the gluteal muscle.
- - - - Natesto is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate
    - - increased prostate specific antigen
      - upper respiratory infection
      - Runny nose
      - Nose bleeding
      - Sore throat
      - Coughs
      - Headache
      - Nose pain
    - - Store Natesto between 20°C to 25°C.
      - Keep Natesto out of the reach of children
    - - administered intranasally three times daily once in the morning, once in the afternoon and once in the evening (6 to 8 hours apart), preferably at the same time each day.
- - - - Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate
    - - Hives
      - swelling of your face, lips, tongue, or throat,
      - Difficulty breathing
      - Pain spreading to your jaw or shoulder
      - Breathing problems at night (sleep apnea)
      - Swelling in your ankles or feet, rapid weight gain,
      - Unusual changes in mood or behavior
      - Seizures
      - Increased or ongoing erection of the penis
      - Decreased amounts of semen,
    - - Stored at room temperature.
    - - Is given by injection into the buttock muscle as directed by your doctor, usually every 1 to 4 weeks.
- - - - Contraindications of the drug Axiron
        Axiron is contraindicated in men with known or suspected carcinoma of the breast or carcinoma of the prostate.
    - - skin redness or irritation at the application site
      - Increased red blood cell count
      - Increase in PSA (prostate-specific antigen)
      - Diarrhea
      - Increase in blood hematocrit,
    - - Keep AXIRON out of reach of children.
      - Store upright at 25°C. Excursions are permitted to 15°C to 30°C.
    - - Topical solution
- - - - Hypersensitivity to clomiphene citrate or components of the formulation
      - Pregnancy
      - Breastfeeding
      - History of hepatic impairment
      - Hepatic diseases
    - - Gastrointestinal disturbance
      - Vasomotor flushing
      - Exacerbation of psychiatric illnesses
      - Headache and dizziness
      - ovarian enlargement
      - Risk of ovarian cancer after prolonged
    - - Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light.
    - - 50 mg Orally tables
- - - - Pregnancy
      - Liver disease, including severe cirrhosis or liver tumors.
      - Allergy or hypersensitivity to any of the implant materials.
      - Personal history of breast cancer.
    - - Mild insulin resistance.
      - Changes to your period. It may stop completely. This is called amenorrhea.
      - Higher risk of noncancerous, or benign, ovarian cysts.
      - Pain in the back or stomach area.
    - - In a cool dry place where the temperature stays below 30°C.
    - - Placed under the skin of the upper arm.
      - The implant releases a low, steady dose of the hormone progestin.
      - A contraceptive implant is a flexible plastic rod about the size of a matchstick that is
- - - - Vagifem is an estrogen (estradiol) indicated for the treatment of atrophic vaginitis due to menopause.
  - - - Undiagnosed abnormal genital bleeding
      - Known, suspected, or history of breast cancer
      - Known anaphylactic reaction or angioedema to Vagifem
      - Known or suspected pregnancy
      - Known liver impairment or disease
      - Known or suspected estrogen-dependent neoplasia
    - - Shortness of breath
      - Itchy, watery eyes
      - Restricting of the airways and throat
      - Abdominal pain
      - Lightheadedness or dizziness
    - - Store below 25°C. Store in a dry place protected from light.
    - - Intravaginally as a local oestrogen therapy by use of an applicator.
- - - - contraindicated in individuals with any of the following conditions: Undiagnosed abnormal genital bleeding. Known, suspected, or history of breast cancer except in appropriately selected patients being treated for metastatic disease. Known or suspected estrogen-dependent neoplasia.
      - Side effects
        
        Sore breast
        
        Hot flashes and night sweat
        
        Trouble sleeping
        
        Depression
    - - Store at 20° to 25°C; excursions permitted to 15° to 30°C
    - - Injection 25mg, intravenously or intramuscularly.